TP53 and cancer: While neither IDH1 nor IDH2 are classic oncogenes or tumor suppressor genes, and IDHmut is not enough to cause cancer by itself, it may facilitate oncogenesis by extending the window of vulnerability in which additional pro-oncogenic mutations can arise, such as those involving TP53 in IDHmut astrocytomas6.